Biotech stocks that survived April 2 feel the heat of Trump’s new pharma threat
If you thought a 104% tariff on China was bad enough, Trump’s…
Csl Limited (ASX:CSL)
About Csl Limited
Key Information
CSL In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 08/05/2025 | Notification of cessation of securities - CSL | 12.64KB | 281 |
| 05/05/2025 | Shareholder Information Meetings | 3.95MB | 8.9K |
| 10/04/2025 | Notification of cessation of securities - CSL | 12.65KB | 360 |
| 03/04/2025 | CSL Responds to Proposed USA Tariffs | 110.55KB | 1.0K |
| 17/03/2025 | Change of Director's Interest Notice | 203.31KB | 1.8K |
| 13/03/2025 | Notification of cessation of securities - CSL | 12.65KB | 373 |
| 13/03/2025 | Update - Dividend/Distribution - CSL | 15.91KB | 684 |
| 11/03/2025 | Notification regarding unquoted securities - CSL | 16KB | 353 |
Share Price History
Officers & Directors
Insider Transactions
Frequently Asked Questions
|
What ASX sector is CSL?
CSL belongs to the Biotechnology sector. Their Principal Activity is the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.
|
|
When did CSL list on the ASX?
CSL has been listed on the ASX since 1994, following its conversion to a public company 100% owned by the Federal Government in 1991.
|
|
Where is CSL based?
CSL's head office is located in Melbourne, Australia, offering products and services globally.
|